RSS   Newsletter   Contact   Advertise with us

Johnson and Johnson revenue $20.74 billion

Christian Fernsby ▼ | January 22, 2020
Johnson and Johnson announced results for Q4 2019.
Johnson and Johnson
Johnson and Johnson   Pharmaceutical business posted revenue of $10.54 billion
Revenue was $20.74 billion.

Topics: Johnson and Johnson

Pharmaceutical business posted revenue of $10.54 billion, a 3.5% increase year over year.

The company’s consumer unit, which makes beauty products such as Neutrogena, increased 0.9% to $3.5 billion.

J&J’s medical device unit reported revenue of $6.63 billion, down half a percent from last year.

Litigation expenses were $264 million in the quarter, compared to $1.29 billion a year ago.

The company sees 2020 earnings between $8.95 per share and $9.10 a share.